228 related articles for article (PubMed ID: 24971483)
1. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
2. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
[TBL] [Abstract][Full Text] [Related]
3. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
[TBL] [Abstract][Full Text] [Related]
4. TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.
Cubero FJ; Singh A; Borkham-Kamphorst E; Nevzorova YA; Al Masaoudi M; Haas U; Boekschoten MV; Gassler N; Weiskirchen R; Muller M; Liedtke C; Trautwein C
Cell Death Differ; 2013 Nov; 20(11):1580-92. PubMed ID: 23933814
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
Beraza N; Malato Y; Sander LE; Al-Masaoudi M; Freimuth J; Riethmacher D; Gores GJ; Roskams T; Liedtke C; Trautwein C
J Exp Med; 2009 Aug; 206(8):1727-37. PubMed ID: 19635861
[TBL] [Abstract][Full Text] [Related]
6. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
[TBL] [Abstract][Full Text] [Related]
7. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
8. An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration.
Koppe C; Reisinger F; Wehr K; Vucur M; Trautwein C; Tacke F; Heikenwalder M; Luedde T
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319593
[TBL] [Abstract][Full Text] [Related]
9. OTULIN Prevents Liver Inflammation and Hepatocellular Carcinoma by Inhibiting FADD- and RIPK1 Kinase-Mediated Hepatocyte Apoptosis.
Verboom L; Martens A; Priem D; Hoste E; Sze M; Vikkula H; Van Hove L; Voet S; Roels J; Maelfait J; Bongiovanni L; de Bruin A; Scott CL; Saeys Y; Pasparakis M; Bertrand MJM; van Loo G
Cell Rep; 2020 Feb; 30(7):2237-2247.e6. PubMed ID: 32075762
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
11. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
12. RIPK1 protects hepatocytes from death in Fas-induced hepatitis.
Filliol A; Farooq M; Piquet-Pellorce C; Genet V; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJM; Samson M; Le Seyec J
Sci Rep; 2017 Aug; 7(1):9205. PubMed ID: 28835677
[TBL] [Abstract][Full Text] [Related]
13. CXCR6 protects from inflammation and fibrosis in NEMO
Liepelt A; Wehr A; Kohlhepp M; Mossanen JC; Kreggenwinkel K; Denecke B; Costa IG; Luedde T; Trautwein C; Tacke F
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):391-402. PubMed ID: 30476545
[TBL] [Abstract][Full Text] [Related]
14. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Krishna-Subramanian S; Singer S; Armaka M; Banales JM; Holzer K; Schirmacher P; Walczak H; Kollias G; Pasparakis M; Kondylis V
Cell Death Differ; 2019 Dec; 26(12):2710-2726. PubMed ID: 30988397
[TBL] [Abstract][Full Text] [Related]
15. Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
Ehedego H; Mohs A; Jansen B; Hiththetiya K; Sicinski P; Liedtke C; Trautwein C
Oncogene; 2018 Jun; 37(25):3329-3339. PubMed ID: 29551768
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
[TBL] [Abstract][Full Text] [Related]
17. NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.
Tolani B; Matta H; Gopalakrishnan R; Punj V; Chaudhary PM
J Virol; 2014 Jun; 88(11):6345-54. PubMed ID: 24672029
[TBL] [Abstract][Full Text] [Related]
18. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer.
Liedtke C; Trautwein C
Eur J Cell Biol; 2012; 91(6-7):582-9. PubMed ID: 22153863
[TBL] [Abstract][Full Text] [Related]
19. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
[TBL] [Abstract][Full Text] [Related]
20. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.
Welz PS; Wullaert A; Vlantis K; Kondylis V; Fernández-Majada V; Ermolaeva M; Kirsch P; Sterner-Kock A; van Loo G; Pasparakis M
Nature; 2011 Jul; 477(7364):330-4. PubMed ID: 21804564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
